133 related articles for article (PubMed ID: 36476431)
1. Dyngo-4a Induces Neuroblastoma Cell Differentiation Through The AKT and ERK1/2 Pathway.
Huang J; Zhou Y; Zeng S; Xu J; Liu L; Grothusen J; Liu R
CNS Neurol Disord Drug Targets; 2023; 22(10):1526-1534. PubMed ID: 36476431
[TBL] [Abstract][Full Text] [Related]
2. All-Trans-Retinoic Acid Stimulates Overexpression of Tumor Protein D52 (TPD52, Isoform 3) and Neuronal Differentiation of IMR-32 Cells.
Kotapalli SS; Dasari C; Duscharla D; Kami Reddy KR; Kasula M; Ummanni R
J Cell Biochem; 2017 Dec; 118(12):4358-4369. PubMed ID: 28436114
[TBL] [Abstract][Full Text] [Related]
3. Functional decreases in P2X7 receptors are associated with retinoic acid-induced neuronal differentiation of Neuro-2a neuroblastoma cells.
Wu PY; Lin YC; Chang CL; Lu HT; Chin CH; Hsu TT; Chu D; Sun SH
Cell Signal; 2009 Jun; 21(6):881-91. PubMed ID: 19385050
[TBL] [Abstract][Full Text] [Related]
4. PI3K/AKT and ERK regulate retinoic acid-induced neuroblastoma cellular differentiation.
Qiao J; Paul P; Lee S; Qiao L; Josifi E; Tiao JR; Chung DH
Biochem Biophys Res Commun; 2012 Aug; 424(3):421-6. PubMed ID: 22766505
[TBL] [Abstract][Full Text] [Related]
5. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
Lee JH; Kim KT
J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
[TBL] [Abstract][Full Text] [Related]
6. NRF2 Mediates Neuroblastoma Proliferation and Resistance to Retinoic Acid Cytotoxicity in a Model of In Vitro Neuronal Differentiation.
de Miranda Ramos V; Zanotto-Filho A; de Bittencourt Pasquali MA; Klafke K; Gasparotto J; Dunkley P; Gelain DP; Moreira JCF
Mol Neurobiol; 2016 Nov; 53(9):6124-6135. PubMed ID: 26541884
[TBL] [Abstract][Full Text] [Related]
7. Changes in Cell Cycle and Up-Regulation of Neuronal Markers During SH-SY5Y Neurodifferentiation by Retinoic Acid are Mediated by Reactive Species Production and Oxidative Stress.
Kunzler A; Zeidán-Chuliá F; Gasparotto J; Girardi CS; Klafke K; Petiz LL; Bortolin RC; Rostirolla DC; Zanotto-Filho A; de Bittencourt Pasquali MA; Dickson P; Dunkley P; Moreira JCF; Gelain DP
Mol Neurobiol; 2017 Nov; 54(9):6903-6916. PubMed ID: 27771902
[TBL] [Abstract][Full Text] [Related]
8. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
Sheikh A; Takatori A; Hossain MS; Hasan MK; Tagawa M; Nagase H; Nakagawara A
Cancer Sci; 2016 Sep; 107(9):1223-32. PubMed ID: 27357360
[TBL] [Abstract][Full Text] [Related]
9. All-trans-retinoid acid induces the differentiation of P19 cells into neurons involved in the PI3K/Akt/GSK3β signaling pathway.
Fu F; Li LS; Li R; Deng Q; Yu QX; Yang X; Pan M; Han J; Zhen L; Zhang LN; Lei TY; Li DZ; Liao C
J Cell Biochem; 2020 Nov; 121(11):4386-4396. PubMed ID: 31961017
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent.
Miloso M; Villa D; Crimi M; Galbiati S; Donzelli E; Nicolini G; Tredici G
J Neurosci Res; 2004 Jan; 75(2):241-252. PubMed ID: 14705145
[TBL] [Abstract][Full Text] [Related]
11. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
[TBL] [Abstract][Full Text] [Related]
12. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells.
López-Carballo G; Moreno L; Masiá S; Pérez P; Barettino D
J Biol Chem; 2002 Jul; 277(28):25297-304. PubMed ID: 12000752
[TBL] [Abstract][Full Text] [Related]
13. Ionizing radiation induces neuronal differentiation of Neuro-2a cells via PI3-kinase and p53-dependent pathways.
Eom HS; Park HR; Jo SK; Kim YS; Moon C; Jung U
Int J Radiat Biol; 2015 Jul; 91(7):585-95. PubMed ID: 25912236
[TBL] [Abstract][Full Text] [Related]
14. The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma.
Lampis S; Raieli S; Montemurro L; Bartolucci D; Amadesi C; Bortolotti S; Angelucci S; Scardovi AL; Nieddu G; Cerisoli L; Paganelli F; Valente S; Fischer M; Martelli AM; Pasquinelli G; Pession A; Hrelia P; Tonelli R
J Exp Clin Cancer Res; 2022 Apr; 41(1):160. PubMed ID: 35490242
[TBL] [Abstract][Full Text] [Related]
15. Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migration.
Yeh PS; Wang W; Chang YA; Lin CJ; Wang JJ; Chen RM
Cancer Lett; 2016 Jan; 370(1):66-77. PubMed ID: 26454217
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide induces the differentiation of retinoic acid-resistant neuroblastoma cells via upregulation of HoxC9.
Li C; Feng C; Chen Y; Wu P; Li P; Xiong X; Peng X; Wang Z; Li Y
Adv Clin Exp Med; 2022 Aug; 31(8):903-911. PubMed ID: 35467087
[TBL] [Abstract][Full Text] [Related]
17. The effects of retinoic acid on the in vitro and in vivo growth of neuroblastoma cells.
Abemayor E
Laryngoscope; 1992 Oct; 102(10):1133-49. PubMed ID: 1328787
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory mechanism of methylmercury on differentiation of human neuroblastoma cells.
Kim YJ; Kim YS; Kim MS; Ryu JC
Toxicology; 2007 May; 234(1-2):1-9. PubMed ID: 17350151
[TBL] [Abstract][Full Text] [Related]
19. Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
Shi Q; Yu B; Zhang Y; Yang Y; Xu C; Zhang M; Chen G; Luo F; Sun B; Yang R; Li Y; Feng H
Cell Oncol (Dordr); 2023 Dec; 46(6):1763-1775. PubMed ID: 37466744
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements.
Illendula A; Fultang N; Peethambaran B
Oncol Rep; 2020 Sep; 44(3):1013-1024. PubMed ID: 32705280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
